These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Antiplatelet agents and anticoagulants for hypertension. Lip GY; Felmeden DC Cochrane Database Syst Rev; 2004; (3):CD003186. PubMed ID: 15266473 [TBL] [Abstract][Full Text] [Related]
7. Anticoagulation versus placebo for heart failure in sinus rhythm. Lip GY; Shantsila E Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD003336. PubMed ID: 24683002 [TBL] [Abstract][Full Text] [Related]
8. Antiplatelet agents and anticoagulants for hypertension. Lip GY; Felmeden DC; Dwivedi G Cochrane Database Syst Rev; 2011 Dec; 2011(12):CD003186. PubMed ID: 22161375 [TBL] [Abstract][Full Text] [Related]
9. Anticoagulation versus placebo for heart failure in sinus rhythm. Shantsila E; KozieĊ M; Lip GY Cochrane Database Syst Rev; 2021 May; 5(5):CD003336. PubMed ID: 34002371 [TBL] [Abstract][Full Text] [Related]
10. Antiplatelet therapy and anticoagulation in patients with hypertension. Griffin G Am Fam Physician; 2005 Mar; 71(5):897-9. PubMed ID: 15768617 [TBL] [Abstract][Full Text] [Related]
11. Antiplatelet and anticoagulation for patients with prosthetic heart valves. Little SH; Massel DR Cochrane Database Syst Rev; 2003; (4):CD003464. PubMed ID: 14583979 [TBL] [Abstract][Full Text] [Related]
12. Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review. Lip GY; Gibbs CR QJM; 2002 Jul; 95(7):451-9. PubMed ID: 12096150 [TBL] [Abstract][Full Text] [Related]
13. Dipyridamole for preventing stroke and other vascular events in patients with vascular disease. De Schryver EL; Algra A; van Gijn J Cochrane Database Syst Rev; 2003; (1):CD001820. PubMed ID: 12535415 [TBL] [Abstract][Full Text] [Related]
14. Antiplatelet and anticoagulation for patients with prosthetic heart valves. Massel DR; Little SH Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD003464. PubMed ID: 23839768 [TBL] [Abstract][Full Text] [Related]
15. The Warfarin and Antiplatelet Therapy in Heart Failure trial (WATCH): rationale, design, and baseline patient characteristics. Massie BM; Krol WF; Ammon SE; Armstrong PW; Cleland JG; Collins JF; Ezekowitz M; Jafri SM; O'Connor CM; Packer M; Schulman KA; Teo K; Warren S J Card Fail; 2004 Apr; 10(2):101-12. PubMed ID: 15101020 [TBL] [Abstract][Full Text] [Related]
16. Anticoagulants versus antiplatelet agents for acute ischaemic stroke. Berge E; Sandercock P Cochrane Database Syst Rev; 2002; (4):CD003242. PubMed ID: 12519590 [TBL] [Abstract][Full Text] [Related]
17. Oral anticoagulants versus antiplatelet therapy for preventing further vascular events after transient ischaemic attack or minor stroke of presumed arterial origin. Algra A; de Schryver EL; van Gijn J; Kappelle LJ; Koudstaal PJ Cochrane Database Syst Rev; 2001; (4):CD001342. PubMed ID: 11687110 [TBL] [Abstract][Full Text] [Related]
18. Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal. Prom R; Usedom JE; Dull RB Ann Pharmacother; 2014 Feb; 48(2):226-37. PubMed ID: 24259641 [TBL] [Abstract][Full Text] [Related]